✦ LIBER ✦

CD34+ cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients

✍ Scribed by Mark Ringhoffer; Markus Wiesneth; Stephanie von Harsdorf; Richard F. Schlenk; Anita Schmitt; Peter P. Reinhardt; Margit Moessner; Wolfgang Grimminger; Thomas Mertens; Sven N. Reske; Hartmut Döhner; Donald Bunjes

Book ID: 108672746
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 178 KB
Volume: 126
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2004.05062.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunologic recovery of patients given C

Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases

✍ Schulenburg, A; Kalhs, P; Worel, N; Höcker, P; Knöbl, P; Greinix, H T 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 43 KB

Long-term results after transplantation

Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors

✍ Hans-Georg Kopp; Stefan Wirths; Christoph Faul; Wolfgang Bethge; Stefan Scheding 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 260 KB

Allogeneic transplantation of CD34+-sele

Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation

✍ Urbano-Ispizua, A; Brunet, S; Solano, C; Moraleda, J M; Rovira, M; Zuazu, J; de 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

The addition of allogeneic peripheral bl

The addition of allogeneic peripheral blood-derived progenitor cells to bone marrow for transplantation: results of a randomised clinical trial

✍ Szer, J. ;Curtis, D. J. ;Bardy, P. G. ;Grigg, A. P. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 630 KB

High-dose therapy in patients with Hodgk

High-dose therapy in patients with Hodgkin’s disease: the use of selected CD34+ cells is as safe as unmanipulated peripheral blood progenitor cells

✍ Blystad, A K; Holte, H; Kvaløy, S; Smeland, E; Delabie, J; Kvalheim, G 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

Cost-effectiveness of CD34+ dose in peri

Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin’s lymphoma patients: a single centre study

✍ Limat, S; Woronoff-Lemsi, M C; Deconinck, E; Racadot, E; Jacquet, M; Herve, P; C 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB